Receptor Subtype

Localization

Receptor coupling

Antagonists (partially selective)

H1

endothelium, brain, smooth muscle

IP3, DAG

N/A

H2

mast cells, gastric mucosa, cardiac muscle, brain

cAMP

ranitidine (Zantac), tiotidine

H3

presynaptic: brain, mesenteric plexus (other neurons)

G protein coupled

N/A

return to main menu

  • Receptor subtypes --
    • intracellular G protein interactions
  • H1: --endothelial and smooth muscle cell localization
    • activation causes
      1. phosphoinositol hydrolysis
      2. increase intracellular calcium
  • H2 -- gastric mucosa, cardiac muscle cells, immune cell localization:
    • activation causes
      • cAMP
  • H3: primarily presynaptic
    • activation causes transmitter release {transmitters: histamine,acetylcholine, norepinephrine, serotonin)
      • decrease may be due to reduced calcium influx (N-type calcium channel)

return to main menu

Organ System Effects

  • Cardiovascular:
    • systolic and diastolic blood pressure
      • histamine vasodilates acting: on arterioles and precapillary sphincters
      • vasodilation due in part to nitric oxide (endothelium-derived relaxing factor, EDRF)
    • heart rate
      1. reflex tachycardia
      2. direct action
    • Both H1 and H2 receptors involved in cardiovascular responses.
    • Histamine-associated edema:H1 receptor effects (postcapillary vessels)
      • increase in vessel permeability due to separation of endothelial cells, allowing transudation of fluid and molecules as large as small proteins.
        • responsible for urticaria (hives)
        • endothelial cell separation: secondary to histamine-induced calcium influx causing intracellular actin/myosin-mediated contraction
    • Direct cardiac effects:
      1. increased contractility (positive inotropism)
      2. increased pacemaker rate (positive chronotropism)

return to main menu

return to main menu

 

  • Bronchiolar smooth muscle
    • H1 receptor mediated bronchoconstriction
    • inhaled histamine:diagnostic, provocative test for bronchial hyperreactivity (asthma or cystic fibrosis)

return to main menu

  • Nerve Endings:
    • sensory nerve ending stimulant (particularly endings mediating pain and itching)
    • H1 receptor mediated effect: part of local reaction to insect stings; urticarial responses

return to main menu

  • Secretory tissue:
    • Stimulant:
      1. gastric acid secretion (significant stimulant)
      2. gastric pepsin
      3. intrinsic factor production
    • Mechanism of Action:
      • H2 receptor mediated effects on gastric parietal cells
      • adenylyl cyclase activity,cAMP, intracellular calcium
      • (acetylcholine and gastrin stimulate gastric acid released but do not increase cyclic AMP)

return to main menu

  • Triple Response:
    • intradermal histamine injection: wheal-and-flare-- three cell types
      1. smooth muscle in the microcirculation
      2. endothelium: capillary or venular
      3. sensory nerve endings
    • Sequence following histamine injection
      1. reddening (small vessel dilatation)
      2. edematous wheal (injection site)
      3. flare (irregular, surrounding wheal) -- caused by axon reflex
    • Wheal-and-flare effects can be induced by histamine releasing agents (agents 48/80, morphine, etc.) -- mainly an H1 receptor-mediated effect
Some Histamine H2 Receptor Agonists

Betazole

Impromidine

return to main menu

  • Histamine:Clinical Pharmacology-- uses
    • historical: test for gastric acid secreting capability (pentagastrin, currently used)
    • historical: diagnosis of pheochromocytoma (histamine promotes substantial catecholamine release) -- direct measurement of catecholamine and catecholamine metabolite concentration is now performed:
    • Pulmonary Function: histamine aerosol may be used to test for bronchial hyperreactivity.
  •  Toxicity:
    • Flushing, hypotension, tachycardia, headache, bronchoconstriction, gastrointestinal disturbances
    •  should not be given to asthmatics (except with extreme caution in pulmonary function testing)
    •  should not be given to patients with active ulcer disease or gastrointestinal hemorrhage.

return to main menu

Burkhalter, A, Julius, D.J. and Katzung, B. Histamine, Serotonin and the Ergot Alkaloids (Section IV. Drugs with Important Actions on Smooth Muscle), in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 261-286.
Friedman, L. S. and Peterson, W.L. Peptic Ulcer and Related Disorders In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., and Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp. 1597-1616.